Advertisement

Topics

Two TB survivors challenge Janssen’s new bedaquiline patent in India

08:33 EST 11 Feb 2019 | British Medical Journal

Two tuberculosis survivors have opposed a patent application filed in India by Janssen Pharmaceutica, which they say could block generic versions of bedaquiline, a drug recommended for the treatment...

Original Article: Two TB survivors challenge Janssen’s new bedaquiline patent in India

NEXT ARTICLE

More From BioPortfolio on "Two TB survivors challenge Janssen’s new bedaquiline patent in India"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Infectious-diseases
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...

Generics Drugs
A generic drug (generic drugs, short: generics) is a drug defined as "a drug product that is comparable to brand/reference listed drug product in dosage form, strength, route of administration, quality and performance characteristics, and intended u...